1.
Chinese Journal of Endocrinology and Metabolism
; (12): 998-1001, 2013.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-439313
ABSTRACT
Hypogonadotropic hypogonadism (HH) is a heterogeneous group of diseases with variable clinical manifestations.Currently,the primary treatment of HH is hormone replacement therapy,including testosterone replacement for induction of pubertal development and gonadotropin therapy or pulse GnRH administration for induction of spermatogenesis.